If you've been following the rapid evolution of weight loss medications, you've probably heard whispers about cagrilintide
Whats happening now is like a large-scale, open-label, public human trial thats being done on these drugs, the long-term consequences of which we dont know, noted Phillips
Sikiric et al., 2006
With B12 deficiency becoming common so is supplementing through B12 injections
Results continue building with additional cycles
Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)